Such risks and uncertainties include, without limitation, market conditions, failure or delay of European, Canadian, U.S. Food and Drug Administration and other regulatory reviews and approvals, competitive developments affecting the Company???s product candidates, delays in product development or clinical trials or other studies, patent disputes and other intellectual property developments relati